Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Surrozen, Inc./DESRZN · Entity 6092 | Director | May 13, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Surrozen, Inc./DE
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.14 · Expires 2036-05-12 | Direct | 5,550 |
Reported balance
After 2026-05-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 5,550 · Balance 5,550 F1: The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2026 Filed May 14, 2026 20:29 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantDirector Stock Option (right to buy) · Derivative | 5,550 | $0.00 Strike: $30.14 | $0.00 |
DisclosureSEC source: 0001193125-26-224157 · ownership.xml · derivative · entry 1 Haak-Frendscho Mary · CIK 0001873902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,550 Underlying: Common Stock · 5,550 shares Expires 2036-05-12 F1 · derivative.exercise_date: The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director. Read SEC document |
| May 14, 2025 Filed May 15, 2025 21:25 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantOption (right to buy) · Derivative | 1,333 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001593968-25-000611 · primary_01.xml · derivative · entry 1 Haak-Frendscho Mary · CIK 0001873902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,333 Underlying: Common Stock · 1,333 shares Expires 2035-05-14 F1 · derivative.exercise_date: The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 00:26 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantOption (right to buy) · Derivative | 1,333 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000830 · primary_01.xml · derivative · entry 1 Haak-Frendscho Mary · CIK 0001873902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,333 Underlying: Common Stock · 1,333 shares Expires 2034-06-05 F1 · derivative.exercise_date: The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:10 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001593968-23-000838 · primary_01.xml · derivative · entry 1 Haak-Frendscho Mary · CIK 0001873902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-05-18 Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 21:52 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001593968-22-001112 · primary_01.xml · derivative · entry 1 Haak-Frendscho Mary · CIK 0001873902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Surrozen, Inc. Common Stock · 20,000 shares Expires 2032-06-07 F1 · derivative.exercise_date: The options fully vest and become exercisable on the one-year anniversary of the grant date, subject to the reporting person's continuous service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.